51 results
S-3ASR
EX-4.1
j39 nex83w4q3ubo
24 Nov 23
Automatic shelf registration
9:30am
S-3ASR
EX-4.2
ha3jonsj
24 Nov 23
Automatic shelf registration
9:30am
8-K
EX-99.1
q1x7p m9lw3eatjkboh
3 Aug 23
Intellia Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
7:45am
DEFA14A
pwr7vcyzsc t07
5 Jun 23
Additional proxy soliciting materials
5:16pm
8-K
EX-99.1
iv2o kyoza
5 Jun 23
Departure of Directors or Certain Officers
4:52pm
8-K
EX-99.1
w583eyj
4 May 23
Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
7:41am
PRE 14A
gil6q8jd4sxo3
18 Apr 23
Preliminary proxy
4:16pm
8-K
EX-99.1
6qz9q50vrzfnlyf0
17 Apr 23
Intellia Therapeutics Names Bill Chase to its Board of Directors
4:59pm
8-K
EX-1.1
mckc36
1 Dec 22
Entry into a Material Definitive Agreement
5:22pm